Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial

User: Guest

Document type:: Zeitschriftenaufsatz
Author(s):: Buhmann, Raymund; Michael, Stanglmaier; Juergen, Hess; Horst, Lindhofer; Peschel, Christian; Kolb, Hans-Jochem
Title:: Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
Journal title:: Journal of Translational Medicine
Year:: 2013
Journal volume:: 11
Journal issue:: 1
Fulltext / DOI:: doi:10.1186/1479-5876-11-160
Publisher:: Springer Nature
E-ISSN:: 1479-5876
Date of publication:: 02.07.2013
BibTeX

Occurrences: